Japanese Structure Survey of High-precision Radiotherapy in 2012 Based on Institutional Questionnaire about the Patterns of Care
Natsuo Tomita(Aichi Cancer Center), Katsumasa Nakamura(Hamamatsu University School of Medicine), Masahiro Kenjo(Hiroshima University), Takashi Uno(Chiba University), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Takeshi Kodaira(Aichi Cancer Center), Yu Kumazaki(Saitama Medical University), Hiroshi Onishi(University of Yamanashi), Kazuhiko Ogawa(The University of Osaka), Chikako Yamauchi(Shiga Medical Center for Adults), Teruki Teshima(Osaka International Cancer Institute), Takafumi Toita(Okinawa Prefectural Chubu Hospital)
Cited by 13
Related Papers
The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells
|International Journal of Oncology|2017|371
Comprehensive Registry of Esophageal Cancer in Japan, 2009
|Esophagus|2016|258
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|214
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis
|International Journal of Radiation Oncology*Biology*Physics|2001|188